BBVA
PRTK

Banco Bilbao Vizcaya Argentaria’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-105,000
Closed -$548K – 782
2020
Q2 		$548K Buy
105,000
+30,000
+40% +$133K 0.02% 537
2020
Q1 		$236K Hold
75,000
– – 0.01% 604
2019
Q4 		$302K Buy
+75,000
New +$260K 0.01% 610

Other funds holding PRTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's PRTK Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2020, closing a stake of 105,000 shares — an estimated $548K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in PRTK in Q4 2019 and held it in 3 quarters. The position peaked at $548K in Q2 2020. 100 funds tracked by Wall St. Rank hold PRTK as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 105,000 Paratek Pharmaceuticals, Inc. shares in Q3 2020, an estimated $548K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2019 and held it in 3 quarters.
  • Banco Bilbao Vizcaya Argentaria's Paratek Pharmaceuticals, Inc. position peaked at $548K in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.